Pusan National University Hospital

Pusan 602-739

1 studies enrolling now · 8 studies all time

What they study most

Advanced Cholangiocarcinoma, Chronic Hepatitis C, Chronic Myelomonocytic Leukemia, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), FGFR2 Gene Mutation, HCC, HER2-amplified Biliary Tract Cancers, Hepatocellular Carcinoma, Hepatocellular Carinoma, Leukemia, Myeloid, Acute, Liver Cancer, Lupus Erythematosus, Systemic

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) — Recruiting now
• Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia — Recruiting now
• A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib — Completed
• A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers — Completed
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer — Completed
• Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 — Completed
• Study of LJP 394 in Lupus Patients With History of Renal Disease — Stopped early